For Orders in Australia
| Address: 38 Clifton Drive Port Macquarie NSW 2444 Australia |
- Home
- News
- Landmark Long-Term Data from
EORTC’s MINDACT Study
Published in The Lancet Oncology - Long-term results from MINDACT
trial confirm importance of gene
expression signature in choosing
breast cancer patients who can
be spared chemotherapy - ASCO has announced new node
positive genomic testing
guidelines. Read here… - Breast cancer patients could be
spared chemotherapy with new
genetic test, study shows - Targeted Breast Cancer Medical
Treatment Now A Reality
– MINDACT is Out! - 70-Gene Signature Identifies
Breast Cancer Subgroup Unlikely
to Benefit From Adjuvant Chemo - Agendia’s MammaPrint
& BluePrint Test - Agendia Genomic Tests
- Press Releases
- MSAC – MammaPrint DAP
- Landmark Long-Term Data from
- About Us
- Patients
- Oncologists
- Contact Us
- Read the SMH MammaPrint News
Address: 38 Clifton Drive, Port Macquarie NSW 2444
Phone: 02 6583 4479
Fax: 02 6584 0539
Copyright © 2014-2021 Genome Investigation Pty Ltd | Dr Guy Hingston
Designed by Snap Website Centre
Managed by Benn Web Design & Marketing
